Hutch News

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100

Dr. Matthias Stephan named Allen Distinguished Investigator

The $1.5 million award will help translate cutting-edge nanoparticle immunotherapy approach to the clinic
Hutch News - October 30, 2018

Improving cancer vaccines with T-cell programming nanoparticles

Dr. Matthias Stephan receives grant to develop cancer vaccine–optimizing, TCR-programming nanotechnology
Hutch News - July 31, 2018

Nanoparticles take immunotherapy in new direction

Hutch scientist to use nanoparticles to reprogram macrophages to tackle brain tumors
Hutch News - May 30, 2018

Implanted scaffold with T cells rapidly shrinks tumors

A biopolymer structure enriched with nutrients shows how immunotherapy could be adapted for solid tumors, according to a study in The Journal of Clinical Investigation.
Releases - April 24, 2017

Tiny tech reprograms immune cells to fight cancer

Nanoparticles turn immune cells into leukemia-fighting powerhouses while they’re still inside the body
Hutch News - April 17, 2017

Nanoparticles reprogram immune cells to fight cancer

Study in Nature Nanotechnology describes new method to transform immune cells, while inside the body, into leukemia-fighting powerhouses
Releases - April 17, 2017

The right tools for the job: taking immunotherapy to the next level

Dr. Matthias Stephan is combining the fields of immunology, bioengineering and gene therapy to harness the immune system to treat solid tumors
Hutch News - May 22, 2015
Last Modified, August 15, 2019